Page last updated: 2024-10-30

ketotifen and Hemolysis

ketotifen has been researched along with Hemolysis in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research Excerpts

ExcerptRelevanceReference
"Ketotifen is an older molecule that possesses antihistaminic activity and is reported to have additional pharmacological properties."1.31A comparison of the effects of olopatadine and ketotifen on model membranes. ( Brockman, H; Graff, G; Spellman, J; Yanni, J, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brockman, H1
Graff, G1
Spellman, J1
Yanni, J1

Other Studies

1 other study available for ketotifen and Hemolysis

ArticleYear
A comparison of the effects of olopatadine and ketotifen on model membranes.
    Acta ophthalmologica Scandinavica. Supplement, 2000, Issue:230

    Topics: Animals; Cattle; Cell Membrane Permeability; Dibenzoxepins; Dose-Response Relationship, Drug; Drug I

2000